StockData
Biodexa Pharmaceuticals Plc logo

Biodexa Pharmaceuticals Plc (BDRX) stock

BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 1/30
$2.04−0.10 (-4.89%)

Close on Nov 18, 2026Market cap $4.60MP/E –Yield –

Biodexa Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2017 it was £6.67M, up 6.6% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2017Dec 31, 2017£6.67M+6.6%
FY2016Dec 31, 2016£6.26M+379.4%
FY2015Dec 31, 2015£1.31M–

More Biodexa Pharmaceuticals figures

See a number that looks wrong?